… In addition, the exposure to legal liabilities resulting from biotechnology research is
reduced when that research is done by a small firm with limited assets rather than in a large …

… The biotechnology community has therefore been more diffuse, even in its relatively early
stages, with clear clusters of small firms developing near centres of research on the west and …

… Smaller firms show some evidence of recognizing the importance of vertical and horizontal
… in small firms, is of major importance to new technology companies, including biotechnology. …

… We examine this question in the context of Finnish biotechnology industry by analyzing the
… of clusters, we find that neither location in a biotechnology cluster nor cluster characteristics …

… These innovation processes are organized by public research centers as well as small
biotech firms and big pharmaceutical multinationals. Regional motors of an economic use of …

… of cluster creation in biotech, primarily based on five in-depth case studies of biotech clusters
… Until the middle of the 1990s, however, the number of biotech firms was very low and there …

… And if our hypotheses on the evolution of the biotech clustering process are correct,
specific policy considerations are indicated. Clustering is an evolutionary phenomenon where …

… This article traces the trajectory of biotechnology firms, clusters and collaborations in …
investigate Australian firms’ ability to overcome the three challenges characterizing biotechnology: …

… into the UK biotechnology industry. Each provides evidence of the extent and kinds of
collaborations in which small UK biotechnology firms engage – with other small firms, large …

… small firms. While globalisation and local clustering are key characteristics of biotechnology,
a question arises as to whether the fact that clustering developed quickly in the USA, …